㈜유바이오시스

{
  "address": "경기도 성남시",
  "ceo_name": "왕용선",
  "certificate": [
    {
      "cert_number": "20130101000",
      "changes": "",
      "disclosure_date": "2013-02-21",
      "first_cert_date": "2013-02-21",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2013-02-21 ~ 2015-02-20"
    },
    {
      "cert_number": "20150101576",
      "changes": "",
      "disclosure_date": "2015-03-09",
      "first_cert_date": "2013-02-21",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2015-02-21 ~ 2017-02-20"
    },
    {
      "cert_number": "20170111304",
      "changes": "",
      "disclosure_date": "2017-09-25",
      "first_cert_date": "2013-02-21",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2017-09-25 ~ 2019-09-24"
    },
    {
      "cert_number": "20190111571",
      "changes": "",
      "disclosure_date": "2019-10-07",
      "first_cert_date": "2013-02-21",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-09-25 ~ 2021-09-24"
    },
    {
      "cert_number": "20211013020059",
      "changes": "",
      "disclosure_date": "2021-10-13",
      "first_cert_date": "2013-02-21",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2021-09-25 ~ 2024-09-24"
    },
    {
      "cert_number": "20241119030065",
      "changes": "",
      "disclosure_date": "2024-11-19",
      "first_cert_date": "2013-02-21",
      "no": "6",
      "type": "혁신성장유형",
      "valid_period": "2024-09-25 ~ 2027-09-24"
    }
  ],
  "company_name": "㈜유바이오시스",
  "corp_no": "131111-*******",
  "financials": {
    "2022": {
      "capital_stock": 2304055000,
      "cost_of_sales": 1894823000,
      "current_assets": 3134420000,
      "current_liabilities": 960649000,
      "gross_profit": 1210797000,
      "net_income": 602450000,
      "net_income_bs": 602450000,
      "non_current_assets": 3516685000,
      "non_current_liabilities": 1003429000,
      "non_operating_expenses": 117206000,
      "non_operating_income": 24997000,
      "operating_profit": 694659000,
      "revenue": 3105620000,
      "sga_expenses": 516138000,
      "total_assets": 6651105000,
      "total_equity": 4687027000,
      "total_liabilities": 1964078000
    },
    "2023": {
      "capital_stock": 2478565000,
      "cost_of_sales": 2180607000,
      "current_assets": 6440770000,
      "current_liabilities": 1134435000,
      "gross_profit": 1669781000,
      "net_income": 975335000,
      "net_income_bs": 975335000,
      "non_current_assets": 3066001000,
      "non_current_liabilities": 1126063000,
      "non_operating_expenses": 219858000,
      "non_operating_income": 474981000,
      "operating_profit": 720212000,
      "revenue": 3850388000,
      "sga_expenses": 949569000,
      "total_assets": 9506771000,
      "total_equity": 7246273000,
      "total_liabilities": 2260498000
    },
    "2024": {
      "capital_stock": 2478565000,
      "cost_of_sales": 1902136000,
      "current_assets": 5966035000,
      "current_liabilities": 1778435000,
      "gross_profit": 943726000,
      "net_income": 182955000,
      "net_income_bs": 182955000,
      "non_current_assets": 3581997000,
      "non_current_liabilities": 384289000,
      "non_operating_expenses": 101191000,
      "non_operating_income": 212330000,
      "operating_profit": 71816000,
      "revenue": 2845862000,
      "sga_expenses": 871910000,
      "total_assets": 9548032000,
      "total_equity": 7385308000,
      "total_liabilities": 2162724000
    }
  },
  "industry": "그 외 기타 의료용 기기 제조업",
  "investment": [],
  "main_products": "Tendoregen /Cartiregen/ U-Tube",
  "phone": "031-734-****",
  "years": [
    2024,
    2023,
    2022
  ]
}